지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay
Gut and Liver
2015 .01
Improvement of the Accuracy of Hepatitis B Surface Antigen Testing Using a Confirmatory Test
Journal of Laboratory Medicine And Quality Assurance
2021 .01
Letter regarding “Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation”
Clinical and Molecular Hepatology
2024 .04
Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study
Journal of Korean Medical Science
2018 .01
Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen
Clinical and Molecular Hepatology
2024 .04
Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
Gut and Liver
2020 .01
Current Status of Hepatitis B Surface Antigen Neutralization Testing in Korea
Journal of Laboratory Medicine And Quality Assurance
2024 .06
ELISA for Quantitative Determination of Hepatitis B Virus Surface Antigen
Immune Network
2017 .12
Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
Gut and Liver
2017 .01
RNA interference as a novel treatment strategy for chronic hepatitis B infection
Clinical and Molecular Hepatology
2022 .07
A Study on the Trend of Changes in the Positive Rate of Hepatitis B Surface Antigens and Antibodies over the Last 9 Years in One Health Care Center
대한의생명과학회지
2023 .12
Efficacy of prolonged entecavir monotherapy for partial virologic response to entecavir in treatment-naïve chronic hepatitis B patients
Clinical and Molecular Hepatology
2015 .01
COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B
Immune Network
2023 .10
The role of different viral biomarkers on the management of chronic hepatitis B
Clinical and Molecular Hepatology
2023 .04
Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
Clinical and Molecular Hepatology
2021 .10
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
Clinical and Molecular Hepatology
2017 .01
Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients
Clinical and Molecular Hepatology
2024 .07
Hepatitis B Virus Infection Is Associated with Poor Prognosis in Patients with Advanced Non Small Cell Lung Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C
Annals of Laboratory Medicine
2018 .01
Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B
Gut and Liver
2023 .03
0